Diabetes Mellitus: all 11,089 studies
Page 110 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)CompletedNCT00130481Not applicable
- Trial of New Dietary Treatment of DiabetesTerminatedNCT00128089Phase 1
- Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesCompletedNCT00127634Phase 3
- Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and SyringeCompletedNCT00127296Phase 1
- LOADD (Lifestyle Over and Above Drugs in Diabetes) StudyStatus unknownNCT00124553Not applicable
- Atorvastatin and Endothelial Function in Type 2 Diabetes Mellitus (ATTEND-Study)CompletedNCT00124397Phase 4
- Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
- The Impact of Pharmacist Recommendations on Quality of Care in Diabetic PatientsCompletedNCT00122421Not applicable
- South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes MellitusCompletedNCT00121966Phase 4
- Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00120536Phase 3
- An Online System to Improve Diabetes Self-CareCompletedNCT00119938Not applicable
- Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With DiabetesCompletedNCT00119535Not applicable
- Effectiveness of Home-Based Health Messaging for Patients With Hypertension and DiabetesCompletedNCT00119054Not applicable
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesCompletedNCT00118963Phase 4
- Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietCompletedNCT00118937Phase 4
- Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCompletedNCT00117780Phase 4
- PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary LesionsStatus unknownNCT00116792Phase 2/3
- A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpCompletedNCT00115973Phase 1
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedNCT00115570Phase 3
- CV Disease in Adolescents With Type 2 DiabetesCompletedNCT00114998
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111670Phase 2
- A Study of DPP-IV Inhibitor in Patients With Type 2 DiabetesCompletedNCT00111631Phase 2
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNCT00111540Phase 3
- Effects of PN2034 in Insulin-Dependent Patients With Type 2 DiabetesCompletedNCT00110864Phase 2
- Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)CompletedNCT00110851Phase 2
- Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialCompletedNCT00110448Phase 4
- A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)CompletedNCT00110435Phase 3
- Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 DiabetesCompletedNCT00110370Phase 4
- Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesCompletedNCT00110240Phase 3
- Evaluation of Diabetes Self-Management Consultant CareCompletedNCT00109720Not applicable
- Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 DiabetesCompletedNCT00109434
- Vermont Diabetes Information SystemCompletedNCT00109369Not applicable
- Improving Diabetes in Primary Care (IMPACT)CompletedNCT00108927
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCompletedNCT00108004Phase 3
- Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedNCT00107107Phase 3
- Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNCT00106808Phase 3
- Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCompletedNCT00106366Phase 3
- Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00106340Phase 3
- Internet-based Diabetes Education and Case ManagementCompletedNCT00105898Not applicable
- Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical TrialsCompletedNCT00105352Not applicable
- Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNCT00104182Phase 3
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCompletedNCT00103935Phase 2
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00102466Phase 3
- Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 DiabetesCompletedNCT00102388Phase 3
- Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes MellitusCompletedNCT00102297Phase 1
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00101803Phase 3
- INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCompletedNCT00101751Phase 4
- Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00101712Phase 3
- Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%CompletedNCT00101673Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 DiabetesCompletedNCT00099957Phase 2
- Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00099944Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00099931Phase 3
- Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099918Phase 3
- A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00099905Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00099892Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099866Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00099853Phase 3
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
- Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)CompletedNCT00099515Phase 2
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCompletedNCT00099320Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097877Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT00097279Phase 3
- Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCompletedNCT00097084Phase 3
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCompletedNCT00097071Phase 3
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4
- Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCompletedNCT00095082Phase 3
- Rosiglitazone to Reverse Metabolic Defects in DiabetesCompletedNCT00094796Phase 2
- An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainTerminatedNCT00089557Phase 2
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00085969Phase 2
- Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainCompletedNCT00082316Phase 2
- Genetic Markers of Coronary Heart Disease in Type 2 DiabetesCompletedNCT00078052
- Islet Transplantation for Patients With Type 1 DiabetesCompletedNCT00073281Phase 1
- Prevention of Type 2 Diabetes Mellitus in ChildrenCompletedNCT00073268Phase 1
- Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)CompletedNCT00073255Phase 1
- Diabetes Therapy to Improve BMI and Lung Function in CFCompletedNCT00072904Phase 3
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCompletedNCT00071448Phase 3
- Safety and Efficacy of INGAP-Peptide in Patients With Type 2 DiabetesCompletedNCT00071422Phase 2
- Safety and Efficacy of INGAP-Peptide in Patients With Type 1 DiabetesCompletedNCT00071409Phase 2
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch BiographerCompletedNCT00069628Phase 4
- Assessing Continuous Glucose Monitors in Healthy ChildrenCompletedNCT00069602Phase 4
- Continuous Glucose Monitors for Children With Diabetes MellitusCompletedNCT00069537Phase 4
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- Soy Protein in Early Diabetic NephropathyCompletedNCT00067678Phase 1/2
- Chromium Effects on Insulin and Vascular Function in People at Risk for DiabetesCompletedNCT00067626Phase 2
- VLDL and LDL Particle Types as Coronary Heart Disease Risk FactorsCompletedNCT00065793
- Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 DiabetesCompletedNCT00065676Phase 2
- Pilot Study of Vedic Medicine for Type 2 DiabetesCompletedNCT00065650Phase 2
- Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational DiabetesCompletedNCT00065130Phase 3
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Type 2 Diabetes Primary Prevention for At Risk GirlsCompletedNCT00063674Not applicable
- Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.CompletedNCT00063128Phase 2
- Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionCompletedNCT00060918Phase 4
- Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)TerminatedNCT00058981Phase 2
- Evaluation of a Diabetes Vaccine in Newly Diagnosed DiabeticsCompletedNCT00057499Phase 1
- Study of Ro 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057317Phase 2
- Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes MellitusCompletedNCT00057304Phase 2
- Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes AdolescentsCompletedNCT00046501Phase 3
- Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other TreatmentCompletedNCT00046462Phase 3
- 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.CompletedNCT00046150Phase 3